ADMA Biologics, Inc. (ADMA)

ADMA Biologics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	61.39	103.15	51.35	86.52	51.09	55.92
Cash & Short-Term Investments	61.39	103.15	51.35	86.52	51.09	55.92
Cash Growth	-29.20%	100.86%	-40.65%	69.36%	-8.64%	109.03%
Receivables	137.67	50	27.42	15.51	28.58	13.24
Inventory	196.67	170.24	172.91	163.28	124.72	81.54
Prepaid Expenses	6.93	8.03	5.33	5.1	4.34	3.05
Total Current Assets	402.66	331.41	257.01	270.4	208.73	153.74
Property, Plant & Equipment	78.78	63.34	63.47	68.75	58.2	45.85
Goodwill	3.53	3.53	3.53	3.53	3.53	3.53
Other Intangible Assets	0.49	0.46	0.5	1.01	1.73	2.44
Long-Term Deferred Tax Assets	74.43	84.28	-	-	-	-
Other Long-Term Assets	8.8	5.66	4.67	4.77	4.07	2.11
Total Assets	568.69	488.68	329.18	348.46	276.25	207.67
Accounts Payable	24.02	20.22	15.66	13.23	12.43	11.07
Accrued Expenses	23.48	28.63	30.55	23.19	16.23	8.16
Current Portion of Long-Term Debt	2.34	-	-	-	-	-
Current Portion of Leases	1.3	1.22	1.05	0.91	0.59	0.37
Current Income Taxes Payable	2.79	3.48	-	-	-	-
Current Unearned Revenue	-	0.14	0.18	0.14	0.14	0.14
Other Current Liabilities	2.56	1.85	2.37	1.8	0.98	0.21
Total Current Liabilities	56.49	55.54	49.81	39.27	30.38	19.95
Long-Term Debt	70.08	72.34	130.59	142.83	94.87	92.97
Long-Term Leases	9.4	8.56	9.78	10.7	7.46	4.33
Long-Term Unearned Revenue	1.44	1.55	1.69	1.83	1.98	2.12
Other Long-Term Liabilities	0.09	1.67	2.11	1.85	0.4	0.05
Total Liabilities	137.5	139.66	193.98	196.49	135.08	119.42
Common Stock	0.02	0.02	0.02	0.02	0.02	0.01
Additional Paid-In Capital	665.38	657.58	641.44	629.97	553.27	428.7
Retained Earnings	-211.03	-308.58	-506.26	-478.02	-412.11	-340.47
Shareholders' Equity	431.19	349.02	135.21	151.97	141.17	88.25
Total Liabilities & Equity	568.69	488.68	329.18	348.46	276.25	207.67
Total Debt	83.12	82.12	141.42	154.44	102.92	97.67
Net Cash (Debt)	-21.74	21.03	-90.07	-67.92	-51.83	-41.75
Net Cash Per Share	-0.09	0.09	-0.40	-0.34	-0.37	-0.48
Filing Date Shares Outstanding	238	237.62	228.22	222.16	195.92	121.28
Total Common Shares Outstanding	238.33	236.62	226.06	221.82	195.81	104.9
Working Capital	346.17	275.87	207.21	231.14	178.35	133.79
Book Value Per Share	1.81	1.48	0.60	0.69	0.72	0.84
Tangible Book Value	427.17	345.03	131.18	147.43	135.91	82.28
Tangible Book Value Per Share	1.79	1.46	0.58	0.66	0.69	0.78
Land	-	4.34	4.34	4.34	4.34	4.34
Buildings	-	21.79	20.22	19.54	19.07	17.4
Machinery	-	32.92	32.93	29.2	24.17	20.11
Construction In Progress	-	8.15	2.27	6.73	5.5	3.34
Leasehold Improvements	-	21.07	20.81	17.93	11.13	5.27

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q